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Single nucleotide polymorphisms (SNPs) within nucleotide-binding oligomerization domainecontaining
protein 2 (NOD2) and toll-like receptor (TLR) 5 genes have been recently associated with the incidence and
outcome of infections. In this study, we analyzed 38 patients with septic shock after allogeneic stem cell
transplantation (allo-SCT) for an association of SNPs within NOD2 and TLR5 genes, with susceptibility to
septic shock. One hundred twenty-seven transplant recipients unaffected by any infectious complications
were used as controls. We found a signiﬁcant association between the presence of donor NOD2 SNP13
(3016_3017insC) and the incidence of septic shock (P ¼ .002). In multivariate analysis, donor NOD2 SNP13
appeared as an independent risk factor for the incidence of septic shock after allo-SCT. No association was
found for recipient SNPs (NOD2 and TLR5) and donor NOD2 SNP8, SNP12, and TLR5-Stop SNP. Our results
suggest that NOD2 SNP13 has an impact on the pathophysiology of severe infectious complications and is an
independent risk factor for the development of septic shock after allo-SCT.
 2015 American Society for Blood and Marrow Transplantation.INTRODUCTION
Despite an improvement in therapy in the last years,
sepsis syndrome remains a severe complication and is 1 of
the leading causes of death in patients after allogeneic stem
cell transplantation (allo-SCT) [1-5]. After allo-SCT, patients
are at increased risk because of various factors, such as
prolonged neutropenia, impairment of the mucosal barrier,
acute or chronic graft-versus-host disease (GVHD), and
distinct immunosuppression with delayed recovery of T and
B cell function [6,7].
However, not all individuals sharing the same risk factors
develop sepsis syndrome and it is suggested that genetic
variations might contribute to the susceptibility of infection.
Recently, it has been described that single nucleotidedgments on page 1403.
uests: Matthias Grube, MD, Department
ogy and Oncology, University Hospital
ee 11, 93053 Regensburg, Germany.
@klinik.uni-regensburg.de (M. Grube).
15.05.011
ty for Blood and Marrow Transplantation.polymorphisms (SNPs) within genes of pattern recognition
receptors (PRR), such as toll-like receptors (TLR) and
nucleotide-binding oligomerization domain (NOD)-like re-
ceptors, which are expressed by cells of the innate immune
system to recognize microbial antigens, are associated with
the incidence and outcome of infections [8-16].
The NOD-containing protein 2/caspase recruitment
domain-containing protein 15 (NOD2) is an intracellular
sensor of muramyl dipeptide, a cell wall component of both
gram-positive and gram-negative bacteria [17]. Furthermore,
NOD2 has recently been identiﬁed as cytoplasmatic PRR for
viral antigens [18]. NOD2 is expressed in various cell types
involved in the microbial defense [19-25]. By activating nu-
clear factor kappa B (NF-kB), NOD2mediates the induction of
antimicrobial peptides (defensins) and induces an inﬂam-
matory response in epithelial cells [26]. Our group has
previously shown that SNPs within the NOD2 gene are in-
dependent risk factors for transplantation-related mortality,
development of GVHD and bronchiolitis obliterans after allo-
SCT, and early mortality of nontransplantation patients with
Table 1
Patients and Clinical Characteristics
Characteristic Control Septic Shock P Value
Disease
AML 45 (35) 18 (47)
NHL 19 (15) 5 (13)
CML 10 (8) 2 (5)
ALL 13 (10) 6 (16)
MM 16 (13) 3 (8)
OMF 8 (6) 1 (3)
CLL 7 (5) 0
MDS 5 (4) 2 (5)
Hodgkin disease 2 (2) 0
Others* 2 (2) 1 (3)
Gender .11
Male 72 (57) 27 (71)
Female 55 (43) 11 (29)
Age, mean (range) 47 (18-69) 49 (18-67)
Stem cell source .21
Bone marrow 14 (11) 5 (13)
Peripheral blood 113 (89) 33 (87)
Conditioning .80
Standard 34 (27) 11 (29)
Reduced intensity 93 (73) 27 (71)
Donor type .70
Unrelated 65 (51) 18 (47)
Sibling 62 (49) 20 (53)
Disease stage .30
Early/intermediate 75 (59) 19 (50)
Advanced 52 (41) 19 (50)
GVHD <.001
Grade 0-II 123 (97) 21 (55)
Grade III-IV 4 (3) 17 (45)
AML indicates acute myelogenous leukemia; NHL, non-Hodgkin lymphoma;
CML, chronic myelogenous leukemia; ALL, acute lymphoblastic leukemia;
MM, multiple myeloma; OMF, osteomyeloﬁbrosis; CLL, chronic lymphocytic
leukemia; MDS, myelodysplastic syndrome.
P value calculated by chi-square test. Control group did not have septic
shock. Signiﬁcant P values are shown in bold.
* Others: 2 severe aplastic anemia and 1 breast cancer.
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demonstrated that SNPs within the NOD2 gene are associ-
ated with the susceptibility to various bacterial infections
[15,16,29] and sepsis syndrome [8,12,15,30].
TLR5 is expressed by several cell types involved in the mi-
crobial immune defense (eg, bronchial epithelial cells, mono-
cytes, neutrophils, dendritic cells, and T cells) and is able to
recognize awide variety of pathogenic bacteria by binding to a
highly conserved region of bacterialﬂagellin [31]. Activation of
TLR5 induces an inﬂammatory responseof different cells of the
immune system. An SNP within the ligand binding domain of
the TLR5gene that results in a premature stop codon (common
stop codon polymorphism, TLR5-Stop SNP) and abrogates
TLR5 signaling is associated with susceptibility to various
bacterial infections [31-33]. Recently, our group demonstrated
a signiﬁcant associationwith recipient TLR5-Stop SNP and the
incidence of invasive aspergillosis after allo-SCT [34].
Because both NOD2 and TLR5 are involved in the immune
response to infections, we investigated whether donor and
recipient SNPswithin the NOD2 and TLR5 gene are associated
with the incidence of septic shock in patients after allo-SCT.
MATERIAL AND METHODS
Patients
A total of 165 patients and their donors were analyzed in this retro-
spective study. The individuals underwent allo-SCT between 1998 and 2011
at the University Hospital of Regensburg and were enrolled in a clinical
investigation approved by the institutional research ethics committee. Blood
samples to perform allelic discrimination testswere collected after informed
consent before transplantation. Conditioning and prophylactic immuno-
suppression was performed according to standard protocols. Standard
conditioning regimens consisted of 8 to 12 gray fractionated total body
irradiation followed by high-dose cyclophosphamide or classic busulfan/
cyclophosphamide. Reduced-intensity conditioning consisted mainly of
ﬂudarabine/BCNU and melphalan regimens. Patients receiving allo-SCT
from unrelated donors underwent in vivo T cell depletion with antithymo-
cyte globulin in the context of pretransplantation conditioning. All patients
have been treated with gastrointestinal decontamination (GD) addressing
mainly gram-negative and anaerobic bacteria (ciproﬂoxacin and metroni-
dazole starting from day þ1).
Microbiological cultures (eg, from whole blood, urine, or bron-
choalveolar lavage) were performed according to standard techniques.
Blood cultures were considered positive if a micro-organismwas detected in
at least 1 bottle, except for coagulase-negative staphylococci, for which
2 separate positive blood cultures with the same strain were required.
Among the analyzed individualswere 38 patients with septic shock after
allo-SCT according to international criteria (2 Systemic Inﬂammatory
Response Syndrome [SIRS] criteria, known or suspected infection, and hy-
potension unresponsive to ﬂuid resuscitation alone) [35-37]. Gram-positive
bacteria were identiﬁed in 19 individuals (50%) and gram-negative were
identiﬁed in 17 (45%). In 2 patients (5%), cytomegalovirus was identiﬁed as
causing pathogen (atypical pneumonia). Analyzing clinical symptoms and
imaging test results (eg, computed tomography scan or ultrasound) in pa-
tients with septic shock, we found the gastrointestinal tract (17 patients,
45%), the lung (15 patients, 39%), and the urinary tract (2 patients, 5%) to be
the primary sources of infection. In 4 individuals (11%), no focus of infection
could be identiﬁed. However, a pathogen could be identiﬁed in all of these
individuals. Patients with septic shock before allo-SCT were excluded from
the study. We used 127 allo-SCT patients unaffected by septic shock and any
infectious complications as controls.
Individuals were of Caucasian ethnic background only (99 males and 66
females;medianage,47years) andpatients suffered fromacutemyelogenous
leukemia (n ¼ 63), non-Hodgkin lymphoma (n ¼ 24), chronic myelogenous
leukemia (n¼ 12), acute lymphoblastic leukemia (n¼ 19),multiplemyeloma
(n ¼ 19), osteomyeloﬁbrosis (n ¼ 9), chronic lymphocytic leukemia (n ¼ 7),
myelodysplastic syndrome (n ¼ 7), Hodgkin disease (n ¼ 2), or other hema-
tological/oncological diseases (breast cancer [n ¼ 1] and severe aplastic
anemia [n ¼ 2]). There was no signiﬁcant difference between patients with
and without septic shock (controls) in terms of clinical features except grade
of GVHD. Clinical characteristics are shown in Table 1.
Collection of DNA Samples and Typing for SNPs
NOD2 2104C>T (SNP8; Arg702Trp; rs2066844), 2722G>C (SNP12
Gly908Arg; rs2066845), 3016_3017insC (SNP13; rs2066847) [28], and TLR51174C>T (TLR5-Stop SNP; Arg392Ter; rs5744168) [31,38] gene poly-
morphisms were determined by Taqman allelic discrimination test as pre-
viously described [28,38,39]. DNA from individuals has been isolated from
EDTA blood. Samples were analyzed for association between risk for septic
shock and the particular PRR gene polymorphisms.
Statistical Analysis
Hardy-Weinberg equilibrium analysis was performed by chi-square test
for each SNP by comparing the detected genotype distribution with the
theoretical distribution estimated on the basis of the SNP allelic frequencies.
Donor and recipient allele and genotype frequencies between patients with
septic shock and controls were compared by chi-square test and the
cumulative incidence of septic shock was calculated by the Kaplan-Meier
method. In cases where the expected values in any of the cells of the
contingency table were below 5, the Fisher exact test was used instead of
chi-square test.
Multivariate analysis was performed by Cox regression calculation. P
values less than .05 were considered statistical signiﬁcant. Values of hazard
ratio, P, and chi-square were calculated at 95% conﬁdence intervals (CI).
RESULTS
Frequency of NOD2 SNPs and TLR5-STOP SNP
We ﬁrst analyzed the frequency of NOD2 SNP8, SNP12,
SNP13, and the TLR5-Stop SNP in the 165 recipients and their
donors by allelic discrimination. In all of the analyzed in-
dividuals, genotype frequencies did not deviate from those
predicted by the Hardy-Weinberg equilibrium (P > .05). Only
heterozygous and no homozygous mutations were observed
in the study population.
NOD2 allele frequencies for SNP8 were 4.5% for recipients
and 5.2% for donors, those for SNP12 were 1.8% for recipients
and donors, and those for SNP13 were 2.4% for recipients and
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ble to those reported in other studies [40,41]. In 17 donor-
recipient pairs (10%), recipients only, and in 21 pairs (13%),
donors only, had at least 1 NOD2 SNP. Both, recipients and
donors revealed at least 1 SNP in 11 pairs (7%). No SNP could
be detected in 116 pairs (70%, wild type group).
The allele frequency for the TLR5-Stop SNP was 4.8% for
both the recipients and the donors, which is in accordance
with results from recent studies [42,43]. In 13 donor-
recipient pairs (8%), recipients only and in 13 pairs (8%),
donors only had the TLR5-Stop SNP. In 3 pairs (2%), both
recipients and donors had the TLR5-Stop SNP. No SNP could
be detected in 136 pairs (82%, wild type group).Donor and Recipient NOD2 SNP8, SNP12, and TLR5-Stop
SNP and Recipient NOD2 SNP13 are Not Associated with
the Incidence of Septic Shock
We wanted to determine the association of SNPs within
the NOD2 and the TLR5 gene with the occurrence of septic
shock in 165 donor-recipient pairs after allo-SCT. Therefore,
we compared donor and recipient genotype and allele fre-
quencies between patients with septic shock and controls by
chi-square test (Tables 2 and 3 ) and calculated the cumu-
lative incidence of septic shock between individuals with
mutated genes and the wild type group by the Kaplan-Meier
method (data not shown). No statistical difference in relation
to donor and recipient NOD2 SNP8, SNP12, and TLR5-Stop
SNP and recipient NOD2 SNP13 could be detected.Donor NOD2 SNP13 is Signiﬁcantly Associated with the
Incidence of Septic Shock and is an Independent Risk
Factor for the Development of Septic Shock after allo-SCT
Whenwe analyzed the correlation between the incidence
of septic shock and the presence of donor NOD2 SNP13 by
comparing genotype and allele frequencies between patients
with septic shock and controls, we found a signiﬁcantly
higher frequency of the cytosine insertion in the group of
patients with septic shock compared with the controls (8%
versus 2%, P ¼ .01) (Table 3).
Furthermore, performing Kaplan-Meier analysis calcu-
lating the cumulative incidence of septic shock, we found a
signiﬁcantly higher incidence of septic shock in the group of
patients in whom the donor had the NOD2 SNP13 (59%)
compared with the wild type group (22%) (P ¼ .002)
(Figure 1A).Table 2
Distribution of Genotype and Allele Frequencies of Recipient SNPs within NOD2 and
Cell Transplantation
Gene SNP Study Group Genotype Fr
NOD2 2104C>T (SNP8) C/C
Control 117 (92)
Septic shock 33 (87)
2722G>C (SNP12) G/G
Control 122 (96)
Septic shock 37 (97)
3016_3017insC (SNP13) -/-
Control 122 (96)
Septic shock 35 (92)
TLR5 1174C>T C/C
(TLR5-STOP) Control 117 (92)
Septic shock 32 (84)
C indicates cytosine; T, thymidine; C/C, homogeneous cytosine insertion; G, gua
insertion.
Numbers in parenthesis represent percent values. P values were calculated at 95%We could not ﬁnd an association between donor NOD2
SNP13 and the pathogens causing septic shock and the pri-
mary source of infection (eg, gastrointestinal tract, the lung,
or the urinary tract).
Because occurrence of GVHD represents a major risk
factor for the development of septic shock, we analyzed the
relevance of this factor in our study group. Patients exerting
severe GVHD grade III and IV had a signiﬁcantly higher
cumulative incidence of septic shock (82%) compared with
patients withmild tomoderate or without GVHD grade 0 to II
(16%, P < .001) (Figure 1B).
However, in 16 of 38 individuals (42%), septic shock
occurred without pre-existing GVHD and was signiﬁcantly
correlated to donor NOD2 SNP13. Furthermore, in a multi-
variate analysis performed by Cox regression, donor NOD2
SNP13 and GVHD grade III and IV both appeared as inde-
pendent risk factors for the development of septic shock
(Table 4).DISCUSSION
Recently, SNPs within TLR and NOD-like receptor genes
have been associated with the incidence and outcome of
infections [8-16]. Based on results of previous studies of our
group [8,27,28,34,39,44], we wanted to determine whether
NOD2 and TLR5 SNPs are related to the incidence of septic
shock in patients after allo-SCT.
Analyzing donor and recipient allele and genotype
frequencies between patients with septic shock and controls
and determining the cumulative incidence of septic shock
after allo-SCT, we found a signiﬁcant association between
donor NOD2 SNP13 and the incidence of septic shock. Our
data are in accordance with recently published studies,
indicating that NOD2 SNP13 is a signiﬁcant risk factor for
sepsis or sepsis-related mortality in patients who did not
undergo transplantation [8,15,30]. Furthermore, Jaskula et al.
recently reported that donor and/or recipient NOD2 SNP13 is
an independent risk factor for sepsis in the context of
allo-SCT [12].
Different consequences of NOD2 SNPs might explain the
increased susceptibility to septic shock in our patients. NOD2
is an important regulator of inﬂammatory immune re-
sponses and is expressed by several cell types involved in the
microbial defense (eg, intestinal and bronchial epithelial
cells, cells of the monocyte/macrophage lineage, neutrophils,
NK cells and T lymphocytes) [19-25]. It is mainly recognizing
bacterial cell wall components but was also recentlyTLR5 Genes in Patients with and without Septic Shock after Allogeneic Stem
equency Allele Frequency P Value
C/T T/T C T
10 (8) 0 (0) 244 (96) 10 (4)
5 (13) 0 (0) 71 (93) 5 (7) .33
G/C C/C G C
5 (4) 0 (0) 249 (98) 5 (2)
1 (3) 0 (0) 75 (99) 1 (1) .38
-/C C/C - C
5 (4) 0 (0) 249 (98) 5 (2)
3 (8) 0 (0) 73 (96) 3 (4) .19
C/T T/T C T
10 (8) 0 (0) 244 (96) 10 (4)
6 (16) 0 (0) 70 (92) 6 (8) .16
nine; insC, cytosine insertion; -/-, no insertion; -/C, heterozygous cytosine
conﬁdence interval. Signiﬁcant P values are shown in bold.
Table 3
Distribution of Genotype and Allele Frequencies of Donor SNPs within NOD2 and TLR5 Genes in Patients with andwithout Septic Shock after Allogeneic Stem Cell
Transplantation
Gene SNP Study Group Genotype Frequency Allele Frequency P Value
NOD2 2104C>T (SNP8) C/C C/T T/T C T
Control 116 (91) 11 (9) 0 (0) 243 (96) 11 (4)
Septic shock 32 (84) 6 (16) 0 (0) 70 (92) 6 (8) .22
2722G>C (SNP12) G/G G/C C/C G C
Control 122 (96) 5 (4) 0 (0) 249 (98) 5 (2)
Septic shock 37 (97) 1 (3) 0 (0) 75 (99) 1 (1) .38
3016_3017insC (SNP13) -/- -/C C/C - C
Control 122 (96) 5 (4) 0 (0) 249 (98) 5 (2)
Septic shock 32 (84) 6 (16) 0 (0) 70 (92) 6 (8) .01
TLR5 1174C>T C/C C/T T/T C T
(TLR5-STOP) Control 114 (90) 13 (10) 0 (0) 241 (95) 13 (5)
Septic shock 35 (92) 3 (8) 0 (0) 73 (96) 3 (4) .23
P values were calculated at 95% conﬁdence interval. Signiﬁcant P values are shown in bold.
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NOD2 stimulation, the transcription factor NF-kB is activated
inducing proinﬂammatory genes modulating innate and
adaptive immune responses [26]. NOD2 SNPs reduce theFigure 1. (A) Cumulative incidence of septic shock in relation to the presence
of NOD2 SNP13 in the donor. Cumulative incidence of septic shock between
patients with NOD2 SNP13 present in the donor (n ¼ 11) and the wild type
group (n ¼ 154) was calculated by the Kaplan-Meier method. (B) Cumulative
incidence of septic shock between patients with GVHD grade 0 to II (n ¼ 144)
and GVHD grade III and IV (n ¼ 21) was calculated by the Kaplan-Meier
method.ability of microbial antigens to activate NOD2 and conse-
quently the activation of NF-kB. This results in reduced
production of antimicrobial peptides (defensins) and proin-
ﬂammatory cytokines, altering both innate and adaptive
immune responses [45-47]. Recently, NOD2 SNPs have been
associated with increased permeability of gastrointestinal
and bronchial mucosa, resulting in reduced barrier function
with increased ability of bacterial ligands to enter systemic
circulation [27,48,49]. Furthermore, it has been demon-
strated that NOD2 SNPs result in reduced phagocytosis by
monocytes and in decreased phagocytic and bactericidal
activities of neutrophils [19,50-52].
After allo-SCT, patients become full chimeras in their
hematopoietic compartment but remain recipient type with
respect to their epithelial cells (eg, intestinal and bronchial
epithelium). The fact that only donor SNP13 is signiﬁcantly
associated with septic shock in our study strongly suggests
that impaired functional activity, mainly of cells of the innate
and adaptive immune system with subsequent immune
dysregulation and defective antimicrobial activity, results in
an increased susceptibility to septic shock. It is described that
the recipient macrophage compartment continues to be
present for a considerable time (until about 1 year) after allo-
SCT [53,54]. Because the mean time to onset of septic shock
in our study was 7 months after allo-SCT, it is assumed that
impaired functional activity of immune cells, other than
macrophages, is responsible for the increased susceptibility
to septic shock.Table 4
Multivariate Analysis of Cumulative Incidence of Septic Shock in Relation to
Donor NOD2 SNP13, Disease Stage at SCT, Donor Type, Conditioning
Regimen, Stem Cell Source, and GVHD Grade
Factor Hazard Ratio 95% CI for
Hazard Ratio
P Value
NOD2 SNP13 donor* 3.277 1.28-8.42 .01
Disease stage at SCTy .883 .44-1.77 .73
Donor typez .672 .35-1.30 .24
Conditioning regimenx 2.370 1.00-5.61 .05
Stem cell sourcek .499 .17-1.43 .20
GVHD grade{ 11.184 5.18-24.15 <.001
SCT indicates stem cell transplantation.
Cox regression was used to compare groups and analyze hazard ratios and
signiﬁcance (P). Signiﬁcant P values are shown in bold.
* NOD2 SNP13 donor: donor has NOD2 SNP13.
y Early/intermediate versus advanced stage at SCT.
z Sibling versus unrelated donor.
x Standard versus reduced-intensity conditioning regimen.
k Bone marrow versus peripheral stem cells.
{ Grade 0 to II versus grade III and IV.
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ciation between donor and/or recipient NOD2 SNP13 and the
incidence of sepsis in patients after allo-SCT [12]. When we
analyzed the group in which the donor and/or the recipient
had NOD2 SNP13 in our study, we also found a signiﬁcant
correlation between NOD2 SNP13 and the incidence of septic
shock. However, performing subgroup analysis (separate
analysis of the groups inwhich the donor or the recipient had
NOD2 SNP13) the correlation only remained signiﬁcant in
the group in which the donor had NOD2 SNP13. This obser-
vation was independent of the donor type (unrelated donor
and sibling).
It has been described that the type of GD, preventing
translocation of intestinal bacteria during allogeneic trans-
plantation, interferes with the prognostic signiﬁcance of
NOD2 SNPs in complications after allo-SCT (eg, GVHD and
transplantation-related mortality) [39,44,55]. Because pa-
tients in our study received GD mainly addressing gram-
negative bacteria, it might be argued that results of SNP
relevance could be different in patients receiving decon-
tamination including gram-positive bacteria. Therefore,
prospective multicenter studies analyzing study populations
with homogenous patient characteristics (including GD)
should be performed.
It might be argued that the NOD2 SNP13 is in linkage
disequilibrium with unknown NOD2 SNPs or SNPs within
other genes that are responsible for an increased suscepti-
bility to septic shock. Further validation and functional
studies analyzing the exact mechanisms by which NOD2
SNP13 inﬂuences antigen recognition and subsequent im-
mune modulation are required. In addition, one might pro-
pose that the NOD2 SNP13 is not directly related to
susceptibility to septic shock but rather to other signiﬁcant
risk factors of infectious complications after allo-SCT (eg,
GVHD). However, performing multivariate analysis clearly
identiﬁed the NOD2 SNP13 as an independent risk factor for
the occurrence of septic shock after allo-SCT.
Recently Bruns et al. described an association between
NOD2 SNPs and culture-positive spontaneous bacterial
peritonitis (SNP12 and 13) and bacterascites (SNP8) in pa-
tients with decompensated hepatic cirrhosis [29]. However,
they did not observe a higher incidence of death by infec-
tious complications or sepsis in these patients. In accordance
with other studies, we could not determine an affect of NOD2
SNP8 and SNP12 (either in the donor or recipient) on the
incidence of septic shock and it is suggested that these SNPs
do not play a signiﬁcant role for the pathophysiology of
sepsis [8,12,30,50,56].
Although the TLR5-Stop SNP results in a total defect in
bacterial ﬂagellin recognition [43] and has been recently
associated with an increased susceptibility to certain bacte-
rial infections [31-33], we could not ﬁnd an association
between donor and recipient TLR5-Stop SNP and the inci-
dence of septic shock. It is known that individuals even ho-
mozygous for this mutation are not characterized by severe
primary immunodeﬁciency, suggesting a redundant role for
TLR5 in bacterial host defense. Furthermore, most of the
above-mentioned association studies have been performed
with human individuals in certain risk situations for infec-
tion (eg, individuals from a Legionnaires’ disease outbreak
and preterm infants). Further studies determining the role of
TLR5-Stop SNP in the pathophysiology of sepsis have to be
performed.
In conclusion, our data describe donor NOD2 SNP13 as a
signiﬁcant risk factor for the development of septic shockafter allo-SCT. Selecting an alternative donor and early
identiﬁcation of high-risk patients might allow individual-
ized and risk-adapted prophylactic and therapeutic strate-
gies, thus decreasing the incidence of septic shock after
allo-SCT.
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